Highest-materiality recent filing
Alpha Cognition amends 8-K to add director Sensenig's committee roles, including future Audit Chair
Director Bethany Sensenig appointed to Audit Committee and Governance & Nomination Committee on April 28, 2026.
Alpha Cognition appoints Bethany Sensenig to board of directors
Bethany Sensenig appointed director on April 15, 2026; previously CFO/Head of Ops at Radius Health.
Alpha Cognition settles Galantos royalty obligations for EUR 5.2M one-time payment, ~40% discount
Entered settlement agreement with Galantos Pharma to extinguish all future royalty and milestone obligations under the Memogain APA.
Alpha Cognition sets June 16, 2026 annual meeting; record date April 24, 2026
Annual General Meeting scheduled for June 16, 2026.
Alpha Cognition FY2025 revenue $10.2M, net loss $20.7M; ZUNVEYL bottles up 62% QoQ
FY2025 total revenue $10.2M: ZUNVEYL net product revenue $6.8M + licensing $3.4M.
Director Len Mertz not seeking re-election at 2026 annual meeting
Len Mertz notified Board on Feb 18, 2026, that he will not stand for re-election.
Alpha Cognition grants equity awards to CEO, COO, and interim CFO
CEO Michael McFadden receives 190,549 RSUs vesting 1/3 annually over 3 years, 177,576 stock options with quarterly vesting after first year.
Alpha Cognition replaces auditor Manning Elliott with CBIZ after relocating to Texas
Manning Elliott resigned on Oct 10, 2025, due to not being licensed in Texas after company moved HQ from Canada.
Alpha Cognition replaces auditor Manning Elliott with CBIZ after HQ move to Texas
Manning Elliott resigned as auditor on Oct 10, 2025 due to lack of Texas license after company relocated from Canada.
Alpha Cognition prices $35M oversubscribed public offering at $6.25/share
Gross proceeds of ~$35M from 5.6M shares (incl. pre-funded warrants) at $6.25 per share.
Alpha Cognition enters $75M ATM equity agreement with H.C. Wainwright
ATM agreement allows sale of up to US$75M of common shares at market prices.
Alpha Cognition stockholders approve 2025 Stock Incentive Plan, re-elect six directors
2025 Stock Incentive Plan approved (3,858,186 for, 444,702 against, 35,288 abstain).
Alpha Cognition appoints Robert Wills to Board; John Havens not seeking re-election
John Havens will not stand for re-election at the 2025 annual meeting; no disagreement with company.
Alpha Cognition approves CEO and COO compensation packages totaling $3.5M and $2.3M for FY2025
CEO Michael McFadden: $625K base, $375K bonus target, $2.5M stock options ($3.5M total).
Alpha Cognition issues 34,196-share representative purchase warrant at $7.18
Issued representative purchase warrant to purchase up to 34,196 shares of common stock.
Alpha Cognition closes $46.2M public offering of common shares and pre-funded warrants
Closed underwritten public offering of 8,695,653 common shares and/or pre-funded warrants for net proceeds of ~$46.15 million (or $52.48 million with full underwriter option).
Alpha Cognition approves 1:25 reverse stock split effective Nov 5, 2024 to meet Nasdaq minimum bid
Board approved 1-for-25 reverse split; authorized common shares reduced from ~150.9M to ~6.0M effective Nov 5, 2024.
Alpha Cognition appoints Henry Du as interim CFO replacing Jay Yoo
Jay Yoo resigned as interim Principal Accounting and Financial Officer effective October 21, 2024.
Alpha Cognition appoints Jay Yoo as interim principal accounting and financial officer
Jay Yoo appointed interim Principal Accounting and Financial Officer effective October 2, 2024.
Alpha Cognition shareholders approve quorum increase to 33-1/3% for Nasdaq listing at annual meeting
Quorum for shareholder meetings raised from 5% to 33-1/3% to satisfy Nasdaq Marketplace Rule 5620(c).
Alpha Cognition raises $4.545M via senior convertible notes and warrants
Issued $4,545,000 aggregate principal of senior convertible notes to accredited investors on Sept 24, 2024.
Alpha Cognition raises $4.545M via senior convertible notes and warrants
Gross proceeds of $4.545M from sale of senior convertible notes (10% interest, maturity Sept 2026) and warrants.
Alpha Cognition files management circular for AGM; proposes quorum increase for Nasdaq listing
Annual general meeting set for September 27, 2024; record date August 21, 2024.
Alpha Cognition CFO Don Kalkofen resigns effective Oct 1, 2024 to pursue other opportunities
CFO Don Kalkofen resigned effective October 1, 2024 to pursue other opportunities.
Alpha Cognition Q2 net loss $2.1M; FDA approves ZUNVEYL for Alzheimer's
Q2 2024 net loss $2.1M ($0.01/share) vs Q2 2023 net loss $2.8M ($0.03/share).
Alpha Cognition raises shareholder quorum to 33 1/3% from 5% for Nasdaq listing
Board approved new quorum policy increasing required shares for shareholder meetings from 5% to 33 1/3%.
Alpha Cognition gets FDA approval for ZUNVEYL to treat mild-to-moderate Alzheimer's
FDA approved ZUNVEYL (benzgalantamine) for mild-to-moderate Alzheimer's disease; second oral AD therapy approved this decade.
Spartan Capital fee on planned public offering cut from 2.5% to 1% via Agreement and Waiver dated June 10, 2024.
On April 7, 2025, the Board appointed Robert Wills, Ph.D., (“Dr. Wills”) to the Board and Governance and Nominating Committee, effective April 7, 2025.
On April 7, 2025, John Havens informed Alpha Cognition Inc. (the “Company’) of his intention not to run for re-election to the Board of Directors (the “Board”) of the Company at the Company’s annual meeting of stockholders in 2025.
On October 21, 2024, Mr. Jay Yoo tendered his resignation as interim Principal Accounting and Financial Officer of Alpha Cognition Inc. (the "Company"), effective October 21, 2024.
On October 21, 2024, the Company appointed Mr. Henry Du, age 46, to act as the Company's Vice President of Finance and Accounting and interim Chief Financial Officer effective October 21, 2024.
The Company previously announced the resignation of Mr. Don Kalkofen as Chief Financial Officer on August 27, 2024, effective October 1, 2024.
On October 8, 2024, Alpha Cognition Inc. (the “Company”) appointed Mr. Jay Yoo to act as the Company’s interim Principal Accounting and Financial Officer effective October 2, 2024.
On August 21, 2024, Mr. Don Kalkofen tendered his resignation as Chief Financial Officer of Alpha Cognition Inc. (the “Company”), effective October 1, 2024.
Max materiality 0.90 · Median 0.50 · Most common event other_material